Summary
The product Drostanolone Enanthate 200 mg/ml, manufactured by Hilma Biocare, was analyzed to verify its composition and potency. The sample, identified by batch number 061368, was tested by Janoshik Analytical, a laboratory known for its expertise in pharmaceutical quality testing. The analysis confirmed the presence of Drostanolone Enanthate with a measured concentration of 192.04 mg/ml, reflecting a 3.98% variance below the label claim. These findings indicate that the product is dosed accurately and within acceptable limits.
The testing process was initiated on 24 January 2023, with the sample received on 14 February 2023, and the analysis completed on 15 February 2023. As the sample was submitted and paid for by the reseller, RoidTeam.net, the results warrant careful scrutiny. This report serves an educational purpose, aiming to help consumers make informed decisions about the accuracy and consistency of anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Hilma Biocare
- Product Name: Drostanolone Enanthate
- Active Ingredient: Drostanolone Enanthate
- Batch Number: 061368
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #27470
- Testing Ordered: 24 January 2023
- Sample Received: 14 February 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: RoidTeam.net (Reseller)
- Analysis Paid For By: RoidTeam.net (Reseller)
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 192.04 mg/ml
- Accuracy: 96.02% (3.98% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/27470_HT522E3V9TLF
- Originally Published: https://thinksteroids.com/community/posts/3229935/
Evaluation of Reseller-Funded Testing
This test report was both submitted and funded by the reseller, RoidTeam.net, which necessitates a critical evaluation of the findings. Reseller-funded testing may involve selective sample submission or implicit pressure on the laboratory. However, the credibility of Janoshik Analytical, along with its history of transparency and reliable analysis, adds confidence to the results. Cross-referencing with third-party testing, when available, is recommended to further substantiate the findings.
Conclusion
The analysis demonstrates that Drostanolone Enanthate 200 mg/ml from Hilma Biocare is slightly underdosed compared to its labeled specification but remains within acceptable limits. This report offers valuable insights for educational and harm reduction purposes, encouraging informed decision-making among consumers. Independent validation would further strengthen the confidence in these results.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
